WAVE Life Sciences:聚焦RNA编辑与RNAi疗法的前沿先锋

药研前瞻
Jan 19

摘要:WAVE Life Sciences是一家致力于通过其专有的集成化技术平台开发精准RNA疗法的临床阶段生物技术公司。其核心竞争力源于PRISM平台,该平台创造性地将立体纯化学、多模式RNA靶向与人类遗传学洞察相结合,实现了药物的理性设计,并由此催生了具备“减脂保肌”独特疗效的潜在重磅药物WVE-007。公司的研发管线战略清晰,已从WVE-006(全球首个临床RNA编辑疗法,用于AATD)的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10